Editorial Policy

What we do

Peptide Proof reports what peer-reviewed research has found about peptides and related compounds. Every figure we publish traces to a study you can open and read yourself.

What we do not do

We do not give medical advice. Nothing here is a recommendation to take, avoid, start, or stop anything. Talk to a clinician who knows your history.

We do not publish dosing protocols. Where a study's dosing is relevant we report it as a fact about that study — participants received X over Y weeks — never as guidance.

Commercial content is clearly labelled and never changes what the evidence says. Peptide Proof may carry sponsorships, disclosed affiliate links, and paid products such as guides or reports. Every commercial item is marked as such, sponsors have no say over editorial content, and no evidence rating is ever influenced by a commercial relationship. See our disclosure policy.

How we handle uncertainty

Every article carries a section called What we don't know yet. It is not an afterthought. Most of what is claimed about peptides online rests on animal data, tiny samples, or nothing at all, and saying so plainly is the point of this publication.

We label the evidence behind every article:

• Systematic review — pooled findings across many trials
• Randomized controlled trial — the strongest single-study design
• Human clinical trial — human interventional data
• Animal research — rodent or other animal models only
• Cell research — in vitro only
• No published human results — the registry shows no reported human outcomes

Corrections

If we get something wrong, we fix it and say so. Write to us and cite the study.